v3.25.1
Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Current assets      
Cash and cash equivalents $ 51 $ 129 $ 767
Accounts receivable 30 76 81
Total current assets 81 205 848
Non-current assets      
Long term restricted deposits 11 11 11
Right of use assets   84
Property and equipment, net 32 35 56
Total non-current assets 43 46 151
Total assets 124 251 999
Current liabilities      
Trade and other payables 428 388 473
Stockholders’ loans 158 157
Convertible loans of related parties 31  
Total current liabilities 617 545 473
Non-current liabilities      
Stockholders’ loans   161
Total non-current liabilities   161
Total liabilities 617 545 634
Contingent liabilities and commitments  
Stockholders’ equity (deficit)      
Common stock, par value $0.001 per share, 600,000,000 shares authorized: 71,008,144 and 69,931,056 issued and outstanding as of December 31, 2024 and 2023, respectively 72 70 69
Additional paid-in capital 16,946 16,374 15,135
Accumulated deficit (17,511) (16,738) (14,839)
Total stockholders’ equity (deficit) (493) (294) 365
Total liabilities and stockholders’ equity $ 124 $ 251 $ 999